NeuMoDx Molecular Announces CE Mark for HPV Diagnostic Test

NeuMoDx™ Molecular, a sample-to-result molecular diagnostic company focused on central laboratory customers, announced today it has received CE Mark approval for its molecular diagnostic test for high-risk types of human papillomavirus (HPV), which was developed in collaboration with Self-screen BV (Amsterdam, the Netherlands). HPV is the virus regarded as the major cause of cervical cancer.